Zydus Lifesciences Ltd (BOM:532321)
₹ 964.4 -8.55 (-0.88%) Market Cap: 970.41 Bil Enterprise Value: 965.67 Bil PE Ratio: 22.61 PB Ratio: 4.45 GF Score: 97/100

Q4 2020 Cadila Healthcare Ltd Earnings Call Transcript

Jun 19, 2020 / 09:30AM GMT
Release Date Price: ₹361.95 (-1.00%)
Ganesh Narayan Nayak
Cadila Healthcare Limited - COO & Executive Director

Good evening, ladies and gentlemen. Welcome to our post results teleconference for the Quarter and the year ended March 31, 2020. I do wish that you and your family are safe and healthy during these unprecedented times.

For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Harish Sadana, Chief Strategy Officer; and Vishal Gor, Senior Vice President, Corporate Finance.

Unabated spread of COVID-19 and the resultant lockdown imposed by the governments across the globe since the beginning of the current calendar year has brought a lot of uncertainties to the business operations, not just for us but for organizations across different sectors. Therefore, before moving on to the highlights of the operations for the quarter and the year gone by, let me give you an overview of the actions taken by us to manage our operations in the current scenario and the role played by us to extend the support to the government and the communities at large during these

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot